Arrowstreet Capital’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Arrowstreet Capital’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,277	Closed	-$280K	–	2376
2021 Q1	$280K	Sell	4,277 -9,710	-69%	-$677K	﹤0.01%	2102
2020 Q4	$919K	Sell	13,987 -2,420	-15%	-$158K	﹤0.01%	1857
2020 Q3	$891K	Buy	16,407 +9,914	+153%	+$758K	﹤0.01%	1850
2020 Q2	$619K	Buy	+6,493	New	+$484K	﹤0.01%	1913
2019 Q2	–	Sell	-350	Closed	-$63K	–	1825
2019 Q1	$63K	Buy	+350	New	+$50.6K	﹤0.01%	1695
2016 Q1	–	Sell	-1,881	Closed	-$224K	–	1603
2015 Q4	$224K	Buy	1,881 +530	+39%	+$68.4K	﹤0.01%	1289
2015 Q3	$230K	Buy	1,351 +340	+34%	+$65.2K	﹤0.01%	1251
2015 Q2	$196K	Sell	1,011 -385	-28%	-$71.5K	﹤0.01%	1117
2015 Q1	$207K	Hold	1,396	–	–	﹤0.01%	934
2014 Q4	$218K	Hold	1,396	–	–	﹤0.01%	1178
2014 Q3	$200K	Sell	1,396 -335	-19%	-$48.6K	﹤0.01%	940
2014 Q2	$226K	Sell	1,731 -1,058	-38%	-$134K	﹤0.01%	913
2014 Q1	$341K	Buy	+2,789	New	+$302K	﹤0.01%	1026
2013 Q4	–	Sell	-4,013	Closed	-$450K	–	1331
2013 Q3	$450K	Hold	4,013	–	–	﹤0.01%	806
2013 Q2	$453K	Buy	+4,013	New	+$491K	﹤0.01%	647

Other funds holding SRGA

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Arrowstreet Capital's SRGA Position: Q2 2021 in Review

Arrowstreet Capital sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2021, closing a stake of 4,277 shares — an estimated $280K sold.

Arrowstreet Capital first reported a position in SRGA in Q2 2013 and held it in 15 quarters. The position peaked at $919K in Q4 2020. 89 funds tracked by Wall St. Rank hold SRGA as of Q2 2021.

Arrowstreet Capital reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Arrowstreet Capital sold 4,277 Surgalign Holdings, Inc. Common Stock shares in Q2 2021, an estimated $280K.
Arrowstreet Capital first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 15 quarters.
Arrowstreet Capital's Surgalign Holdings, Inc. Common Stock position peaked at $919K in Q4 2020.
89 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2021.

Based on Arrowstreet Capital's 13F filing for Q2 2021, filed 13 Aug 2021.